AG-348 enhances pyruvate kinase activity in red blood cells from patients with pyruvate kinase deficiency
Authors:
Open Access
- 14 September 2017
- journal article
- Published by American Society of Hematology in Blood
- Vol. 130 (11) , 1347-1356
Abstract
Key Points: AG-348 is a small-molecule allosteric activator of WT red cell pyruvate kinase as well as mutant enzymes associated with hemolytic anemia. Activity in vitro, in mice, and in red blood cells suggests it may address the underlying molecular pathology in PK deficiency patients.Keywords
This publication has 38 references indexed in Scilit:
- Integrated protein quality-control pathways regulate free α-globin in murine β-thalassemiaBlood, 2012
- Metabolic remodeling of the human red blood cell membraneProceedings of the National Academy of Sciences, 2010
- Rescue of Pyruvate Kinase Deficiency in Mice by Gene Therapy Using the Human IsoenzymeMolecular Therapy, 2009
- The energy-less red blood cell is lost: erythrocyte enzyme abnormalities of glycolysisBlood, 2005
- Red cell pyruvate kinase deficiency: molecular and clinical aspectsBritish Journal of Haematology, 2005
- Ineffective erythropoiesis in the spleen of a patient with pyruvate kinase deficiencyAmerican Journal of Hematology, 2003
- Quinine protects pyruvate‐kinase deficient red cells from dehydrationAmerican Journal of Hematology, 1979
- Normalisation of red blood cell pyruvate kinase in pyruvate kinase deficiency by riboflavin treatmentClinica Chimica Acta, 1975
- A Low Km Phosphoenolpyruvate Mutant in the Amish with Red Cell Pyruvate Kinase DeficiencyBritish Journal of Haematology, 1969
- HÆMOLYTIC ANÆMIA DUE TO PYRUVATE-KINASE DEFICIENCYThe Lancet, 1963